Kliniken der Stadt Köln gGmbH, Krankenhaus Merheim, Klinikum der Privaten Universität Witten/Herdecke, Institut für Pathologie, Ostmerheimer Str. 200, D-51109 Köln (Cologne), Germany.
Pathogens. 2013 Jan 11;2(1):1-12. doi: 10.3390/pathogens2010001.
Human bocavirus (HBoV) was identified as the second human parvovirus with pathogenic potential in 2005 in respiratory samples from children suffering from viral respiratory infections of unknown etiology. Since its first description, a large number of clinical studies have been performed that address the clinical significance of HBoV detection and the molecular biology of the virus. This review summarizes the most important steps taken in HBoV research to date and addresses open questions that need to be answered in the future to provide a better understanding of the role of a virus that is difficult to grow in cell culture and is suspected to be a pathogen, although it has not yet fulfilled Koch's postulates.
人博卡病毒(HBoV)于 2005 年在患有病因不明的病毒性呼吸道感染的儿童的呼吸道样本中被鉴定为具有潜在致病性的第二种人类细小病毒。自首次描述以来,已经进行了大量的临床研究,探讨了 HBoV 检测的临床意义和病毒的分子生物学。这篇综述总结了迄今为止在 HBoV 研究中采取的最重要步骤,并解决了未来需要回答的悬而未决的问题,以便更好地了解一种难以在细胞培养中生长且被怀疑是病原体的病毒的作用,尽管它尚未满足科赫假设。